Hematology News

Adequate evidence exists to show betibeglogene autotemcel confers a net health benefit vs. standard clinical management for patients with beta-thalassemia, according to a final evidence report by Institute for Clinical and Economic Review.

Blood viscosity calculated using the Walburn-Schneck model may serve as an effective prognostic tool in hospitalized patients with SARS-CoV-2 infection, according to data published in the Journal of the American College of Cardiology.

Adults with isolated distal deep vein thrombosis experience fewer short- and long-term adverse outcomes compared with those with proximal DVT, including major bleeding and venous thromboembolism deterioration, data show.

A good teacher in any area of medicine can define a student’s path and course of specialty.

Among adults without anemia presenting for elective cardiac surgery, iron deficiency was not associated with fewer days alive and at home when assessed at postoperative day 30 or 90, researchers reported in The Lancet Haematology.

The FDA granted fast track designation to abelacimab for treatment of cancer-associated thrombosis, according to a press release from the agent’s manufacturer.

Among patients with African ancestry, those with sickle cell trait are at a higher risk for COVID-19–related death, according to data published in JAMA Internal Medicine.

Individuals with non-O blood types had an increased risk for venous thromboembolism 3 months after a cancer diagnosis or recurrence, according to study results published in Blood Advances.

World Sickle Cell Day is observed each year on June 19.

An investigational CRISPR/Cas9 gene-edited cell therapy demonstrated significant, durable efficacy among patients with transfusion-dependent beta-thalassemia and sickle cell disease, according to study results.